Oropharyngeal excretion of Epstein-Barr virus by renal transplant recipients and other patients treated with immunosuppressive drugs.

Lancet (London, England) ·Vol. 1 ·No. 7851 ·1974-02-16 ·Pages 234-7

Strauch B, Andrews LL, Siegel N, Miller G

Abstract

暂无摘要

MeSH Terms

Adolescent Adult Antibodies, Viral/isolation & purification Azathioprine/therapeutic use Carrier State Child Child, Preschool Female Fluorescent Antibody Technique Herpesvirus 4, Human/immunology,isolation & purification Humans Immunity, Cellular Immunosuppressive Agents/adverse effects Kidney Transplantation Leukocytes/immunology Male Middle Aged Mouth/microbiology Mucus/microbiology Pharynx/microbiology Postoperative Care Prednisone/therapeutic use Prospective Studies Therapeutic Irrigation Transplantation, Homologous

Chemicals

Antibodies, Viral Immunosuppressive Agents Azathioprine Prednisone

Authors & Affiliations

4 authors, click to expand affiliations / ORCID

Strauch B

Andrews L L

Siegel N

Miller G

Article Info

Journal

Lancet (London, England)

Abbr.

Lancet

ISSN

0140-6736

DOI

10.1016/s0140-6736(74)92546-x

Published

1974-02-16

Pages

234-7

Language

English

Region

England

NLM ID

2985213R

Subset

External Links

PubMed source DOI: 10.1016/s0140-6736(74)92546-x View journal details

Analysis Services

Oropharyngeal excretion of Epstein-Barr virus by renal transplant recipients and other patients treated with immunosuppressive drugs.

Contact

WeChat Official Account